Page 3 - Bruce Cree News Today

Published: Feb 25, 2021 GAITHERSBURG, Md., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today reported updated safety, efficacy and long-term use results of UPLIZNA ® (inebilizumab-cdon), including interim data from the open-label extension period (OLP) of the pivotal N-MOmentum trial in patients wi...

email article Neuromyelitis optica spectrum disorder (NMOSD) is a rare, disabling, sometimes fatal central nervous system inflammatory demyelinating disease, with features that make a diagnosis challenging. First, noted Bruce Cree, MD, clinical research director of the Multiple Sclerosis Center at the University of California San Francisco, there is a lot of clinical overlap between neuromyelitis optica and multiple sclerosis (MS). "And for the better part of the preceding century there w...